• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.56% Nasdaq Down 0.79%

    Biogen Inc. (BIIB)

    -NasdaqGS
    263.12 Down 10.59(3.87%) May 4, 4:00PM EDT
    |After Hours : 264.97 Up 1.85 (0.70%) May 4, 7:40PM EDT
    Prev Close:273.71
    Open:271.70
    Bid:261.04 x 100
    Ask:267.00 x 100
    1y Target Est:345.67
    Beta:0.3261
    Earnings Date:Jul 22 - Jul 26 (Est.)
    Day's Range:262.44 - 271.75
    52wk Range:242.07 - 420.99
    Volume:1,788,237
    Avg Vol (3m):1,783,100
    Market Cap:57.64B
    P/E (ttm):17.15
    EPS (ttm):15.34
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Related Video

    Comparison

    Symbol% ChgMkt Cap
    BIIBDown 3.87%57.64B
    PFEDown 0.89%206.81B
    ABTDown 1.17%55.99B

    Key Statistics

    Forward P/E (1 yr):13.10
    P/S (ttm):5.56
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :18.83
    Quarterly EPS Est (Jun-16) :4.66
    Mean Recommendation*:2.1
    PEG Ratio (5 yr expected):1.48

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Biogen Inc. discovers, develops, manufactures, and delivers therapies for the treatment of neurodegenerative diseases, hematologic conditions, and autoimmune disorders. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback